Akorn, Inc. Announces the Appointment of Dr. Adrienne Graves, Ph.D. to its Board of Directors

March 6, 2012 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

LAKE FOREST, Ill.--(BUSINESS WIRE)--Akorn, Inc. (NASDAQ: AKRX), a niche generic pharmaceutical company, announced today that its Board of Directors appointed Dr. Adrienne Graves, Ph.D., as Director of the Company, effective March 2, 2012.

Twitter
LinkedIn
Facebook
Email
Print

People